Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Randomized Controlled Trial

Research Support, Non-U.S. Gov't

Clinical Trial

Review

Comparative Study

Systematic Review

Meta-Analysis

Letter

Case Reports

Evaluation Study

Multicenter Study

Publication Year

From

Quick links

Individual year

2023

2021

2019

2018

2017

2016

2015

2014

2012

2011

2010

2009

2007

2006

2005

2004

2003

2002

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Flutamide""[mesh_terms]

33 Results

Searching titles within these results

Rapid equilibrium dialysis, ultrafiltration or ultracentrifugation? Evaluation of methods to quantify the unbound fraction of substances in plasma.

Dorothee Funk-Weyer, Robert Landsiedel, Eric Fabian, Dunja Dimitrijevic

Biochemical and biophysical research communications 2023;651():114-120

Full Text

Abstract

An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer.

Sam Ladjevardi, Hans Lennernäs, Taina Isotalo, Kimmo Taari, Jan Weis, Michael Häggman, Teuvo L Tammela, Håkan Ahlström, Carl-Gustaf Gölander, Niklas Axén, Anna Tolf, Bo Lennernäs, Cecilia Wassberg, Catrin von Below

The Journal of urology 2019;198(6):1333-1339

Full Text

Abstract

PCOS.

David Cahill

BMJ clinical evidence 2016;2009():1408

Free Full Text

Abstract

Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation.

Lourdes Ibáñez, Carme Valls, Angela Ferrer, Ken Ong, David B Dunger, Francis De Zegher

The Journal of clinical endocrinology and metabolism 2002;87(6):2870-4

Full Text

Abstract

Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide.

L Ibáñez, N Potau, M V Marcos, F de Zegher

The Journal of clinical endocrinology and metabolism 2000;85(9):3251-5

Full Text

Abstract

Pioglitazone (7.5 mg/day) added to flutamide-metformin in women with androgen excess: additional increments of visfatin and high molecular weight adiponectin.

Lourdes Ibáñez, Abel López-Bermejo, Marta Díaz, Goya Enríquez, Carme Valls, Francis de Zegher

Clinical endocrinology 2012;68(2):317-20

Full Text

Abstract

Ketoconazole and Flutamide in the treatment of disseminated intravascular clotting from prostate cancer: a case report and review.

S Chakrapee-Sirisuk, K Amornpichetkul, S Visudhiphan, T Sangruchi, V Srimuninnimit, P Sinlarat

Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2002;84(10):1495-501

Full Text

Abstract

Effects of ethinylestradiol-cyproterone acetate vs. pioglitazone-flutamide-metformin on plasma FGF21 levels in adolescent girls with androgen excess.

J M Gallego-Escuredo, L Ibáñez, F Villarroya, F de Zegher, M Díaz

Diabetes & metabolism 2017;42(3):196-9

Full Text

Estrogen therapy in patients with prostate cancer: a contemporary systematic review.

Herney Andrés García-Perdomo, Emerson Luis Zani, Leonardo Oliveira Reis

International urology and nephrology 2018;50(6):993-1003

Full Text

Abstract

Prospective randomised trial comparing diethylstilboestrol and flutamide in the treatment of hormone relapsed prostate cancer.

Nick Burns-Cox, Vanessa Basketter, Bernard Higgins, Simon Holmes

International journal of urology : official journal of the Japanese Urological Association 2003;9(8):431-4

Free Full Text

Abstract

Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.

Feridun Karakurt, Ibrahim Sahin, Serdar Güler, Berrin Demirbas, Cavit Culha, Rustu Serter, Yalcin Aral, Nuket Bavbek

Advances in therapy 2009;25(4):321-8

Full Text

Abstract

Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception.

Francis De Zegher, Lourdes Ibáñez

The Journal of clinical endocrinology and metabolism 2003;88(10):4720-4

Full Text

Abstract

Caffeine test in predicting flutamide-induced hepatic injury in patients with prostate cancer.

S Ozono, A Yamaguchi, H Mochizuki, T Kawakami, K Fujimoto, T Otani, K Yoshida, M Ichinei, T Yamashita, Y Hirao

Prostate cancer and prostatic diseases 2003;5(2):128-31

Full Text

Abstract

Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.

Lourdes Ibáñez, Carme Valls, Sergi Cabré, Francis De Zegher

The Journal of clinical endocrinology and metabolism 2004;89(9):4716-20

Full Text

Abstract

Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.

Alessandra Gambineri, Carla Pelusi, Silvia Genghini, Antonio Maria Morselli-Labate, Mauro Cacciari, Uberto Pagotto, Renato Pasquali

Clinical endocrinology 2004;60(2):241-9

Full Text

Abstract

Results: 1 – 15 / 33

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Flutamide""[mesh_terms]

Rapid equilibrium dialysis, ultrafiltration or ultracentrifugation? Evaluation of methods to quantify the unbound fraction of substances in plasma.

An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer.

PCOS.

Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation.

Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide.

Pioglitazone (7.5 mg/day) added to flutamide-metformin in women with androgen excess: additional increments of visfatin and high molecular weight adiponectin.

Ketoconazole and Flutamide in the treatment of disseminated intravascular clotting from prostate cancer: a case report and review.

Effects of ethinylestradiol-cyproterone acetate vs. pioglitazone-flutamide-metformin on plasma FGF21 levels in adolescent girls with androgen excess.

Estrogen therapy in patients with prostate cancer: a contemporary systematic review.

Prospective randomised trial comparing diethylstilboestrol and flutamide in the treatment of hormone relapsed prostate cancer.

Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.

Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception.

Caffeine test in predicting flutamide-induced hepatic injury in patients with prostate cancer.

Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.

Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.

Results for
""Flutamide""[mesh_terms]